RAVICTI

Peak

glycerol phenylbutyrate

NDAORALLIQUID
Approved
Feb 2013
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2

Clinical Trials (2)

NCT03335488Phase 4Completed

Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)

Started Feb 2018
16 enrolled
Urea Cycle Disorder
NCT02246218Phase 4Completed

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

Started Dec 2014
27 enrolled
Urea Cycle Disorder

Loss of Exclusivity

LOE Date
Mar 9, 2032
73 months away
Patent Expiry
Mar 9, 2032

Patent Records (5)

Patent #ExpiryTypeUse Code
9999608
Sep 22, 2030
U-1816
10045959
Sep 22, 2030
U-1816
10183002
Sep 22, 2030
U-1816
10183003
Sep 22, 2030
U-1816
10183004
Sep 22, 2030
U-1816